MIRAGRON S 50/5: Manage Overactive Bladder Effectively

MIRAGRON S 50/5

Mirabegron (ER) (50mg) and Solifenacin succinate (5mg)

MIRAGRON S 50/5 combination of Mirabegron (ER) (50mg) and Solifenacin succinate (5mg) is a combination medication used to treat overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency. This powerful combination offers dual action by addressing multiple pathways involved in bladder control.

What is Mirabegron (ER) (50mg)?

Mirabegron is an extended-release beta-3 adrenergic agonist that helps relax the bladder muscle, increasing its storage capacity and reducing the urgency and frequency of urination.

• Primary Uses

  • Treatment of overactive bladder (OAB) symptoms.
  • Management of urge urinary incontinence.
  • Reduction of urinary frequency and urgency.

• Key Benefits

  • Increases bladder capacity.
  • Reduces the number of incontinence episodes.
  • Improves quality of life by decreasing urinary urgency.

• Dosage and Administration

• Swallow the tablet whole; do not crush, chew, or split.

  • Follow the healthcare provider's instructions for best results.

• Possible Side Effects

  • Common: High blood pressure, nasopharyngitis, urinary tract infection.
  • Serious: Palpitations, chest pain, allergic reactions (rare).

What is Solifenacin succinate (5mg)?

Solifenacin succinate is an antimuscarinic agent that works by relaxing the bladder muscles, thereby reducing involuntary contractions and improving bladder control.

• Primary Uses

  • Treatment of overactive bladder (OAB) symptoms.
  • Management of urinary urgency and frequency.
  • Reduction of urge urinary incontinence.

• Key Benefits

  • Decreases bladder muscle spasms.
  • Reduces episodes of urinary incontinence.
  • Improves control over urination and reduces frequency.

• Dosage and Administration

• Swallow the tablet whole with water.

  • Adhere to the prescribed dosage and instructions.

• Possible Side Effects

  • Common: Dry mouth, constipation, blurred vision.
  • Serious: Severe allergic reactions, difficulty urinating (rare).

MIRAGRON S 50/5:

Comprehensive Overactive Bladder Treatment MIRAGRON S 50/5 combines the benefits of Mirabegron (ER) and Solifenacin succinate, providing a comprehensive approach to managing overactive bladder symptoms.

• Enhanced Benefits

  • Dual mechanism of action addresses multiple pathways.
  • Reduces urinary frequency and urgency effectively.
  • Improves overall bladder control and quality of life.

• Precautions

• Not suitable for individuals with certain medical conditions without medical supervision.

Conclusion:

MIRAGRON S 50/5, combining Mirabegron (ER) (50mg) and Solifenacin succinate (5mg), is an effective treatment for overactive bladder. Its dual-action approach helps to reduce urinary frequency, urgency, and incontinence, significantly improving the quality of life for patients. Always consult your healthcare provider to ensure that MIRAGRON S 50/5 is the right choice for your condition.Steris Healthcare Pvt Ltd, established in February 2018 by seasoned professionals in the pharmaceutical sector, operates under the name Sterispharma. Headquartered in Navi Mumbai, the company is certified by WHO, GMP, and ISO. Sterispharma is dedicated to providing high-quality medications at affordable prices across India, adhering to stringent WHO guidelines. They offer an online pharmacy platform for easy medicine purchases and home delivery. The company's mission is to deliver a diverse range of healthcare products catering to the varied needs of the medical community. From advanced treatments and rare condition medications to essential health supplies, Sterispharma aims to meet the extensive demands of the healthcare industry. Their product range covers numerous health fields, including Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

For further information: 

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488

BUY NOW